Skip to main content
Fig. 5 | BMC Complementary Medicine and Therapies

Fig. 5

From: A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

Fig. 5

Fold-changes of cytotoxic activity of PBMCs against CL-6 cell compared with baseline levels in blood samples from healthy Thai subjects following the administration of (a) single oral dose of 1000 mg and (b) multiple oral doses of 1000 of standardized AL extract for 21 days (n = 20 for AL and n = 4 for each group). Data are presented as median (range) values

Back to article page
\